ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Daré Bioscience (DARE)
Daré Bioscience stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · NASDAQ
$0.67▲ +3.45%
Prices as of Oct 27, 2026 · USD
Chance of rising in 1 month
47%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Daré Bioscience in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Daré Bioscience
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Daré Bioscience a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $0.59 and $0.74; in 9 out of 10, between $0.48 and $0.91. Estimated annual volatility is 65%.
Price, last 12 months (weekly close)
Key numbers
- 52-week high
- $3.78
- 52-week low
- $0.63
- Revenue (12 months)
- $1.4M
- Revenue growth (YoY)
- +10,430.0%
- Gross margin
- 71.3%
- Return on equity
- -471.4%
- Free cash flow (12 months)
- $-6.9M
- Beta
- 1.01
What this means
ATLAS does not publish a fair value for DARE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks DARE has traded between $0.63 and $3.78. Today it is 82.4% below that high and 6% above its low.
Its beta is 1.01: it moves roughly in line with the market.
About the company
Daré Bioscience, Inc. is a clinical-stage biopharmaceutical company focused on women’s health.
Want to see everything about Daré Bioscience?
Get started →Plans from €3.99 a month.
Frequently asked questions
What does Daré Bioscience do?
Daré Bioscience, Inc. is a clinical-stage biopharmaceutical company focused on women’s health.
What is the chance DARE goes up next month?
47%: close to a coin flip. In half of the simulated outcomes, DARE ends the month between $0.59 and $0.74.
How volatile is DARE?
ATLAS estimates annual volatility at 65%. In a typical month, half of the outcomes end between $0.59 and $0.74.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer